Chromothripsis is particularly associated with tumour development in patients with Li-Fraumeni syndrome as they bear germline TP53 mutations22, but may also be more generally associated with partial insufficiency in TP53 or other genes linked to DNA damage responses such as ATM22,47. The gene discussed is TP53; the disease is neoplasm.